efavirenz 600 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet

RxCUI: 864661
RxNorm name: efavirenz 600 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet
Display name: efavirenz 600 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet
Full name: efavirenz 600 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:06

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate	EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE	Laurus Labs Limited	1f8f9fe1-b8fd-4f65-8832-9d3d6802d076	2023-11-15	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 864661
SYMFI	EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE	Viatris Specialty LLC	81a55dd9-78a8-49c3-88ab-8f5bffafa359	2019-10-15	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 864661

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
81a55dd9-78a8-49c3-88ab-8f5bffafa359	efavirenz 600 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet	SCD	6	These highlights do not include all the information needed to use SYMFI safely and effectively. See full prescribing information for SYMFI . SYMFI ® (efavirenz, lamivudine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018	20191015
81a55dd9-78a8-49c3-88ab-8f5bffafa359	efavirenz 600 MG / lamiVUDine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet	PSN	6	These highlights do not include all the information needed to use SYMFI safely and effectively. See full prescribing information for SYMFI . SYMFI ® (efavirenz, lamivudine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018	20191015
81a55dd9-78a8-49c3-88ab-8f5bffafa359	efavirenz 600 MG / 3TC 300 MG / Tenofovir disoproxil fumarate 300 MG Oral Tablet	SY	6	These highlights do not include all the information needed to use SYMFI safely and effectively. See full prescribing information for SYMFI . SYMFI ® (efavirenz, lamivudine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018	20191015
81a55dd9-78a8-49c3-88ab-8f5bffafa359	efavirenz 600 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet	SY	6	These highlights do not include all the information needed to use SYMFI safely and effectively. See full prescribing information for SYMFI . SYMFI ® (efavirenz, lamivudine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018	20191015
1f8f9fe1-b8fd-4f65-8832-9d3d6802d076	efavirenz 600 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet	SCD	2	These highlights do not include all the information needed to use EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2018	20231115
1f8f9fe1-b8fd-4f65-8832-9d3d6802d076	efavirenz 600 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet	SY	2	These highlights do not include all the information needed to use EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2018	20231115
1f8f9fe1-b8fd-4f65-8832-9d3d6802d076	efavirenz 600 MG / 3TC 300 MG / Tenofovir disoproxil fumarate 300 MG Oral Tablet	SY	2	These highlights do not include all the information needed to use EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2018	20231115
1f8f9fe1-b8fd-4f65-8832-9d3d6802d076	efavirenz 600 MG / lamiVUDine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet	PSN	2	These highlights do not include all the information needed to use EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2018	20231115